Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Psychological factors and brain magnetic resonance imaging metrics associated with fatigue in persons with multiple sclerosis.
Hechenberger S, Helmlinger B, Penner IK, Pirpamer L, Fruhwirth V, Heschl B, Ropele S, Wurth S, Damulina A, Eppinger S, Demjaha R, Khalil M, Pinter D, Enzinger C. Hechenberger S, et al. Among authors: heschl b. J Neurol Sci. 2023 Nov 15;454:120833. doi: 10.1016/j.jns.2023.120833. Epub 2023 Oct 10. J Neurol Sci. 2023. PMID: 37866195 Free article.
COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
Bsteh G, Assar H, Hegen H, Heschl B, Leutmezer F, Di Pauli F, Gradl C, Traxler G, Zulehner G, Rommer P, Wipfler P, Guger M, Enzinger C, Berger T; AUT-MuSC investigators. Bsteh G, et al. Among authors: heschl b. PLoS One. 2021 Jul 27;16(7):e0255316. doi: 10.1371/journal.pone.0255316. eCollection 2021. PLoS One. 2021. PMID: 34314457 Free PMC article.
Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study.
Bsteh G, Dürauer S, Assar H, Hegen H, Heschl B, Leutmezer F, Pauli FD, Gradl C, Traxler G, Zulehner G, Rommer P, Wipfler P, Guger M, Höftberger R, Enzinger C, Berger T. Bsteh G, et al. Among authors: heschl b. Mult Scler. 2021 Dec;27(14):2209-2218. doi: 10.1177/13524585211049391. Epub 2021 Oct 1. Mult Scler. 2021. PMID: 34595968 Free PMC article.
Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
Hodl I, Sallegger C, Forstner P, Sareban N, Moritz M, Dreo B, Schulz E, Lackner A, Kleinhappl B, Hatzl S, Moazedi-Fürst F, Seifert-Held T, Heschl B, Khalil M, Enzinger C, Greinix H, Stradner MH, Steinmetz I, Schlenke P, Fessler J. Hodl I, et al. Among authors: heschl b. Microbes Infect. 2023 May;25(4):105103. doi: 10.1016/j.micinf.2023.105103. Epub 2023 Jan 19. Microbes Infect. 2023. PMID: 36681177 Free PMC article.
Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control study.
Bsteh G, Assar H, Gradl C, Heschl B, Hiller MS, Krajnc N, Di Pauli F, Hegen H, Traxler G, Leutmezer F, Wipfler P, Zulehner G, Guger M, Enzinger C, Berger T; AUT-MuSC-19 investigators. Bsteh G, et al. Among authors: heschl b. Eur J Neurol. 2022 Jun 25:10.1111/ene.15477. doi: 10.1111/ene.15477. Online ahead of print. Eur J Neurol. 2022. PMID: 35751475 Free PMC article.
Impact of vaccination on COVID-19 outcome in multiple sclerosis.
Bsteh G, Gradl C, Heschl B, Hegen H, Di Pauli F, Assar H, Leutmezer F, Traxler G, Krajnc N, Zulehner G, Hiller MS, Rommer P, Wipfler P, Guger M, Enzinger C, Berger T; AUT-MuSC investigators. Bsteh G, et al. Among authors: heschl b. Eur J Neurol. 2022 Jul 5:10.1111/ene.15488. doi: 10.1111/ene.15488. Online ahead of print. Eur J Neurol. 2022. PMID: 35791496 Free PMC article.
11 results